Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232581 | 0.83 | PRCP (0.32) | PRCP | |
| SCHEMBL3711367 | 0.82 | PRCP (0.32) | PRCP | |
| SCHEMBL230172 | 0.73 | PRCP (0.32) | PRCP | |
| SCHEMBL13280965 | 0.72 | — | — | |
| SCHEMBL232814 | 0.72 | GRIN1 (0.31) | — | |
| SCHEMBL1758838 | 0.63 | PBRM1 (0.34) | — | |
| SCHEMBL1758870 | 0.63 | — | — | |
| SCHEMBL13280964 | 0.58 | — | — | |
| SCHEMBL9370080 | 0.58 | GRIN1 (0.49) | PRCP | |
| SCHEMBL929054 | 0.58 | GRIN1 (0.49) | PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8986654-B2 | Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use | DANPET AB (SE) | 2015-03-24 | — | — | US | disclosed |
| US-20140030190-A1 | LABELLED AND UN-LABELLED METHYL-PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE | DANPET AB (SE) | 2014-01-30 | — | — | US | disclosed |
| US-20120288443-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NEUROSEARCH A/S (DK) | 2012-11-15 | — | — | US | disclosed |
| US-20120288443-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NEUROSEARCH A/S (DK) | 2012-11-15 | — | — | US | disclosed |
| WO-2012139925-A1 | LABELLED AND UN-LABELLED METHYL-PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE | NEUROSEARCH A/S (DK) | 2012-10-18 | — | — | WO | disclosed |
| EP-2498826-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NeuroSearch AS (DK) | 2012-09-19 | — | — | EP | disclosed |
| EP-2498826-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NeuroSearch AS (DK) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011058002-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NEUROSEARCH A/S (DK) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011058002-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NEUROSEARCH A/S (DK) | 2011-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120288443-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | GRM3, SSTR3, OXGR1 | PRCP 2616/4885 |
| US-20140030190-A1 | LABELLED AND UN-LABELLED METHYL-PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE | GRM3, CNR1, CNR2 | PRCP 3639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.